Despite their rarity and physiologically neutral character, more inherited structural variants of serum albumin (alloalbumins) are known than for any other human protein except hemoglobin. Including three previously unreported examples described here, we have identified 13 different point substitutions in alloalbumins of Japanese origin. Of these only albumin B and two proalbumins have been reported in other ethnic groups, and these are the most common variants of European origin. Some alloalbumins of Asiatic origin, but not yet identified in Japanese, are present in diverse ethnic groups. An alloalbumin found in indigenes of New Guinea (lysine -* asparagine at position 313) is also present in Caucasians of various European descents. Albumin Lambadi, occurring in a tribal group in south India, has a mutation (glutamic acid -* lysine at position 501) also found as a rare variant in individuals of diverse ethnic origin resident on four continents. These results suggest that some alloalbumins with the same substitution may have originated by independent mutations in various populations. This, together with the apparent clustering of point substitutions in the protein structure, may reflect hypermutability of the albumin gene.
(lysine -* asparagine at position 313) is also present in Caucasians of various European descents. Albumin Lambadi, occurring in a tribal group in south India, has a mutation (glutamic acid -* lysine at position 501) also found as a rare variant in individuals of diverse ethnic origin resident on four continents. These results suggest that some alloalbumins with the same substitution may have originated by independent mutations in various populations. This, together with the apparent clustering of point substitutions in the protein structure, may reflect hypermutability of the albumin gene.
Because of recent studies (1-17) more heritable structural variants of serum albumin (alloalbumins) are known than for any other human protein except hemoglobin. However, unlike the situation with hemoglobin variants, no adverse effect on molecular function has been attributed to alloalbumins. Alloalbuminemia is rare and has a cumulative frequency of only 1:3000 to 1:10,000 in most populations (18) (19) (20) (21) (22) (23) (24) (25) ; thus, it is usually expressed in a heterozygous fashion. More than 100 alloalbumins that have been given geographical or tribal names have been identified by genetic screening (18) (19) (20) , by blood donor surveys (21) , or by clinical electrophoresis (22, 23) , and at least 20 different sites of structural change have been determined (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Four types of alloalbumins have been identified: (i) a series of single-point mutants (1-7, 12-14, 16) , (ii) several chain-termination mutants (10, 11) , (iii) proalbumins (variants that retain a basic amino-terminal hexapeptide because of a mutation in the Arg-Arg propeptide sequence required for post-transcriptional processing) (8, 15) , and (iv) arginyl-albumin, a variant that begins with arginine followed by a polypeptide sequence of the usual length (585 amino acid residues) (ref. 17 ; C. B. Laurell and F.W.P., unpublished results).
Recently we have undertaken a series of collaborative studies on alloalbumins from populations throughout the world (1-3, 5, 6) . Our objectives have been to determine the structural changes and to correlate these with the molecular properties ofalbumin and with such genetic characteristics as the site and type of mutation, heritability, and frequency. In this paper we report structural studies on alloalbumins from eight unrelated Japanese residents of Japan or Hawaii and also on one specimen representative of certain New Guinea indigenes (19) and on an alloalbumin identified in the Lambadi tribal population in India (24) . We also report the substitution in albumin Manaus I from Brazil (20) because it is the same as that in albumin Lambadi and several other alloalbumins of Asiatic origin (3).
MATERIALS AND METHODS Sources of Sera. In this study all the sera from Japanese resident in Japan were identified as bisalbuminemic during routine clinical electrophoresis. The sera (generally only 1-2 ml) were from heterozygous individuals and contained approximately equal proportions of the alloalbumin and of normal (common) albumin (called albumin A). The Japanese sera were received from several sources listed in the text, and the alloalbumins are designated by place of origin (city or region). All sera from outside Japan were collected in the course of genetic or epidemiological surveys described in the text.
Methods and Strategy for Structural Study. Because of the number and variety of the specimens reported here and the fact that most of the methods have been published in detail (1) (2) (3) (4) (5) (6) (7) (8) (9) , only a summary of the methods is given for each individual albumin. The general procedure consists of seven steps and was modified as required in each case. The steps are as follows: (i) cellulose"acetate (Microzone) electrophoresis at pH 8.6 of the serum or the purified albumin; (ii) purification by HPLC of the total albumin (normal albumin A plus variant) by a method later referred to as the two-step procedure (4), reduction and carboxymethylation of the purified albumin and cleavage with CNBr (3, 4, 9); (iii) analytical isoelectric focusing of the CNBr digest to identify the CNBr fragment in which the substitution was localized (3) (4) (5) (6) (7) (8) ; (iv) HPLC peptide mapping on a preparative scale to purify the variant CNBr fragment (1-4); (v) HPLC peptide mapping of a tryptic or Staphylococcus aureus V8 protease digest of the purified CNBr fragment (1-5); (vi) amino acid analysis of the variant peptide(s) with the Beckman model 121M amino acid analyzer; and (vii) automated sequence determination with the Beckman model 890C sequencer (9) or with the Applied Biosystems model 477B sequencer. After K.A. returned to Japan he used the Jeol model JLC-200A amino acid analyzer, and he determined the sequence of some peptides by manual Edman degradation (26) . Tryptic peptides are designated T and V8 protease peptides are designated S, and both types are numbered consecutively in their predicted order in the amino acid sequence (9) .
The two-step procedure for purification of albumin consists of a combination of anion-exchange HPLC on a TSK-DEAE 5PW column (7.5 x 75 mm; Anspec, Ann Arbor, MI) and gel filtration with a TSK 4000SW column (7.5 X 600 mm; Anspec) under conditions described elsewhere (3, 4 $To whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 87 (1990) HPLC purification of CNBr fragments and of the tryptic and V8 peptides was done with a Vydac C18 column (4.6 x 250 mm; Anspec) as described (1) (2) (3) (4) (5) . As indicated in the text, some alloalbumins were compared with reference standards by several collaborators, who used starch-gel electrophoresis in a number of buffer systems (2, 6, 19, 21) . The amino acid sequence of albumin A and the codons at each position are based on the genomic sequence of Minghetti et al. (27) .
RESULTS AND DISCUSSION
Structural Studies of Japanese Alloalbumins with Point Substitutions. Three previously unreported point substitutions were identified in Japanese individuals living in various cities in Japan. As described below, these are 119 Glu -* Lys in albumin Nagoya, 563 Asp -> Asn in albumins Fukuoka-1 and Ube-1, and 565 Glu -+ Lys in albumin Osaka-i. Several other alloalbumins were found to have previously reported substitutions. Table 1 gives a summary of single amino acid exchanges reported here and elsewhere for alloalbumins of various ethnic and geographic origins. Fig. 1 gives the amino acid sequence of human serum albumin and identifies the location of the substitutions.
Albumin Nagoya. (Serum H160007.) This alloalbumin was discovered in a Japanese family and was present in five members, including the index case (29) . Serum was provided by Makoto Sasaki (Department of Biochemistry, School of Medicine, Nagoya City University, Nagoya, Japan). In clinical electrophoresis at pH 8.6 the variant had a slow mobility (+2 net charge relative to normal albumin; denoted slow, +2). Chiyoko Satoh (Department of Genetics, Radiation Effects Research Foundation, Hiroshima; personal communication) used starch gel electrophoresis at pH 4.05 and pH 8.6 (5, 6) to compare albumin Nagoya with several reference albumins we supplied and with the five alloalbumins discovered in Nagasaki and Hiroshima by the Biochemical Genetics Study of the Radiation Effects Research Foundation. These are designated Nagasaki-1, -2, and -3, and Hiroshima-1 and -2 (5, 6). She reported that the six Japanese variants showed different combinations of mobilities in the two buffer systems and also were different from albumin B and proalbumin Pollibauer (1, 5) .
The two-step HPLC procedure was used to purify the total albumin (albumins A and Nagoya denoted A/Nagoya) from serum H160007. Analytical isoelectric focusing of the CNBr digest did not reveal an abnormal pattern, but the HPLC peptide profile of the CNBr digest suggested the substitution might be in the small fragment CB2 (residues 88-123; see Fig.  1 ). The tryptic peptide profile of purified CB2 was obtained by HPLC on a Vydac C18 column and the amino acid compositions of the separated peptides were determined. This revealed the presence of normal peptide T14 (residues 115-123 of albumin A) and of two new peptides, T14A* and T14B, arising from the point substitution in albumin Nagoya. Peptide T14 from CB2 has the sequence Leu-Val-ArgPro-GlW-Val-Asp-Val-Met (see Fig. 1 ). Amino acid analysis of peptides T14A* and T14B followed by manual sequence analysis gave the sequences Leu-Val-Arg-Pro-Lya and ValAsp-Val-Met, respectively, thus indicating a previously unreported substitution 119 Glu -+ Lys. This was confirmed by automated sequence analysis. This result fits with the slow (+2) mobility of albumin Nagoya and can be explained by a point mutation in the codon for residue 119, GQAG -* AAG.
Albumins Fukuoka-I and Ube-!. Although found in unrelated individuals from different cities in Japan, these alloalbumins are discussed together because structural study was done concurrently and showed that they had the same substitution (563 Asp --Asn). Both (14) 372 Lys -Glu Mersin (7) Naskapi (7) 375 Asp Asn Nagasaki-2 (6) protein sequence is given in the one-letter code and is based on the genomic sequence analysis of Minghetti et al. (27) . The layout of the polypeptide chain, including the domain structure and disulfide bonds, is according to Brown and Shockley (28) . CB1-CB7 refer to CNBr fragments, for which the positions of the amino acid residues are given. The location of the introns (designated 1-13, circled) is from Minghetti et al. (27) . The normal hexapeptide propeptide (Arg-Gly-Val-Phe-Arg-Arg, residues -6 to -1) is illustrated. Substitutions in the propeptide and in the mature albumin are summarized in Table 1 Lys-Cys-Cys-Lys-Ala-Asp-Asp-Lys-L-Thr-Cys-PheAla-Glu-(Glu). The first nine residues correspond to V8 peptide S57 except for the 565 Glu Lys substitution that prevents action of the V8 protease. Partial cleavage appeared to occur after each of the last two glutamic residues, resulting in the composite peptide S57-58-59A*. The 565 Glu --Lys substitution accounts for the slow (+2) mobility and is attributable to a point mutation in the codon jAG to AAG.
On the other hand, the V8 digest of Osaka-2 yielded a variant peptide that automated sequence analysis showed to be S58-59*. This has the sequence Thr-Cys-Phe-Ala-L.Y-Glu, corresponding to residues 566-571, and results from the substitution 570 Glu --Lys, which is characteristic of albumin B (1). Albumin Nagano. This serum was from an individual born in Nagano Prefecture northwest of Tokyo and was provided by I. Sakurabayashi (Department of Clinical Pathology, Jichi Medical School, Tochigi-ken). As shown by the procedure described above for Osaka-2 and detailed elsewhere (1), this slow (+2) variant also was an albumin of the B type with the substitution 570 Glu -Lys. In this case also, the V8 peptide S58-59* was isolated, and analysis with the Applied Biosystems sequencer showed that it had the sequence ThrCys-Phe-Ala-L -Glu. Including Osaka-2 described above, this is the fifth instance of an albumin B in Japanese for which we have established the change in structure. Four of these came from an area not far from Tokyo, in the central part of the island of Honshu. Although rare, this is also one of the most common albumin variants in Caucasians, and the struc- Bisalbuminemia in Hawaii-Japanese. In the course of the Japan-Hawaii Cancer Study, Fukunaga and Glober (22) (8, 15) . The slow (+2) mobility and the susceptibility of the variant to limited tryptic digestion indicated it was a proalbumin. The variant protein was purified by the two-step procedure and was analyzed (without prior carboxymethylation) for 10 cycles in the Beckman sequenator. This gave an unambiguous sequence for a proalbumin with the substitution -1 Arg -. Gln: Arg-Gly-Val-Phe-Arg-Cjn-Asp-Ala-His-Lys.
This substitution explains the slow (+2) mobility and is attributable to the point mutation CGiA CAA. The parents of the propositus for Honolulu-2 migrated from Kumamoto Prefecture, which is on the same island as Fukuoka. We conclude that these Asian examples of proalbumin Christchurch may have arisen from a common ancestor in Japan, but they represent a mutation independent of that which led to the Caucasian proalbumins of the Christchurch type. On the other hand, proalbumin Takefu has thus far been reported only for Japanese.
Bisalbuminemia in India and New Guinea. Although bisalbuminemia has been reported in populations in India and nearby countries (18, 19, 24) and also in New Guinea indigenes (19, 25) , structural study of alloalbumins from defined population groups in these regions has not been published. Two examples from anthropologically distinct tribal groups in India and New Guinea are described below.
Albumin Lambadi andAlbumin Manaus I (501 Glu --Lys). In 1980 Walter et al. (24) reported an apparently new, slow-moving albumin variant occurring in the Lambadi tribal group that lived in the Khamman district of Andra Pradesh in southern India but originated in northern India. Recently we received serum specimens from 12 individuals of the Lambadi tribal group that had been freshly collected by P. Veerraju (Department of Genetics, Andhra University, Waltair, India). One of the sera exhibited bisalbuminemia with a variant of the slow (+2) type.
The total albumin (A/Lambadi) in the serum containing the variant was purified by the two-step procedure. Isoelectric focusing of a CNBr digest indicated the substitution was in CNBr fragment CB6 (residues 447-548). The variant fragment was purified by HPLC on a Vydac C18 column and digested with S. aureus V8 protease. The HPLC profile on Vydac C18 of the V8 protease digest revealed the presence of the variant peptide denoted S50-51* that we had found for albumin Vancouver (see figure 5 of ref. 3 for the HPLC peptide profile and figure 6 for the amino acid sequence). The S50-51* peptide was rechromatographed on Vydac C18 and submitted to amino acid analysis and to manual sequence analysis. The results, which were confirmed by automated sequence analysis, established the amino acid sequence of S50-S51* as Thr-Tyr-Val-Pro-Lys-Lya-Phe-Asn-Ala-Glu-.
Except for the substitution 501 Glu --Lys, this is the same as the sequence of peptide S50-51 for residues 4%-505 in albumin A (see Fig. 1 ). We had earlier identified the same substitution in three Asiatic variants-i.e., albumins Van (4) for albumin Cooperstown. In summary, isoelectric focusing of the CNBr digest showed that the substitution was present in CB4 (residues 299-329, see Fig. 1 ). A variant of peptide S34 was isolated by HPLC from a V8 protease digest of a mixture of the variant CB4 fragment and the normal CB7. Amino acid analysis of this peptide followed by analysis in the Applied Biosystems sequencer showed that it had the sequence for positions 312-321 as follows: Ser-A nAsp-Val-Cys-Lys-Asn-Tyr-Ala-Glu. In this case the lysine at position 313 is replaced by asparagine (313 Lys -i Asn).
The substitution found for albumin New Guinea has also been reported for a series of albumin variants from diverse sources (4, 12, 16, 21 We have previously called attention to the apparent clustering of point substitutions in three short segments of the albumin molecule: (i) the propeptide and the amino terminus, (ii) the connecting segment at the end of the second domain, and (iii) the carboxyl-terminal tailpiece, for which two previously unreported replacements have been added in this work (563 Asp --Asn and 565 Glu -* Lys). Fig. 1 shows that the latter two segments appear to be homologous in position in the second and third domains. Progress is being made in elucidation of the crystallographic structure of human serum albumin (30) . When a higher-resolution structure is determined, it will be of much interest to locate in it the point substitutions listed in Table 1 . Of even greater interest is the question whether the clustering of point substitutions in the protein structure reflects hypermutability of segments of the albumin gene.
